Abstract
Background Non-communicable diseases (NCD) represent a large and rapidly growing disease burden in Malawi and the wider sub-Saharan Africa region. National and regional NCD prevalence estimates and mapping, establishment of associated risk factors, and trend monitoring are vital for sustaining hard-won gains in well-being and life expectancy from the successful management of infectious diseases.
Methods Between 2012 and 2016, blood pressure was measured in a population-representative sample of 29,628 Malawian adults (18+ years) residing in two locations; the southern part of rural Karonga district and urban Area 25 in Lilongwe city. Each location was divided into approximately 200 zones with individuals assigned the zone in which their home was located. A conditional autoregressive (CAR) model was fitted to estimate zonal hypertension prevalence. Estimates were plotted on regional maps featuring key amenities, healthcare facilities, and transport links. Individual-level economic and lifestyle covariates were then incorporated to assess how much of the variation could be explained by those covariates.
Results Variation in hypertension prevalence was observed in both the rural and urban location (P < 0.0005), with high-prevalence zones clustering in areas near to major transport links and/or concentrations of amenities. Covariates explained most of the variation in both sites (P > 0.14).
Conclusions In rural and urban Malawi, hypertension prevalence is higher among those of relatively high wealth, those who are closer to local amenities, or a combination of these two factors. More detailed data are needed to determine if these associations are explained by wealth-consequent behaviours such as sedentary occupations and deleterious lifestyle choices.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the study was granted by the Malawi National Health Sciences Research Committee (NHRSC) protocol number #1072, and LSHTM Ethics Committee protocol number #6303.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is owned and controlled by the Malawi Epidemiology and Intervention Research Unit.
